Searching for your content…
In-Language News
Contact Us
888-776-0942
from 8 AM – 10 PM ET
News provided by
Mar 23, 2022, 14:00 ET
Share this article
DUBLIN, March 23, 2022 /PRNewswire/ — The "Cervical Dysplasia Market Research Report by Diagnostics Type, by Treatment Type, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com’s offering.
The Global Cervical Dysplasia Market size was estimated at USD 622.50 million in 2020, is expected to reach USD 662.38 million in 2021, and is projected to grow at a CAGR of 6.77% to reach USD 984.85 million by 2027.

Market Statistics:
The report provides market sizing and forecast across five major currencies – USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Cervical Dysplasia to forecast the revenues and analyze the trends in each of the following sub-markets:
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cervical Dysplasia Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Cervical Dysplasia Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cervical Dysplasia Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cervical Dysplasia Market?
4. What is the competitive strategic window for opportunities in the Global Cervical Dysplasia Market?
5. What are the technology trends and regulatory frameworks in the Global Cervical Dysplasia Market?
6. What is the market share of the leading vendors in the Global Cervical Dysplasia Market?
7. What modes and strategic moves are considered suitable for entering the Global Cervical Dysplasia Market?

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of cervical cancer
5.1.1.2. Rising initiatives by the government to enhance the screening of cervical dysplasia
5.1.1.3. Emergence of cervical screening programs
5.1.2. Restraints
5.1.2.1. Lack of awareness in developing countries
5.1.2.2. High cost of diagnostic devices
5.1.3. Opportunities
5.1.3.1. Increasing awareness campaigns for the early diagnosis
5.1.3.2. Technological advancements in screening devices and other supporting equipment
5.1.4. Challenges
5.1.4.1. Alteration in regulatory guidelines for cervical cancer screening and use of HPV vaccines
5.2. Cumulative Impact of COVID-19

6. Cervical Dysplasia Market, by Diagnostics Type
6.1. Introduction
6.2. Biopsy
6.3. Colposcopy
6.4. HPV Test
6.5. Pap Smear Test

7. Cervical Dysplasia Market, by Treatment Type
7.1. Introduction
7.2. Chemotherapy
7.3. Radiation Therapy
7.4. Surgery
7.5. Therapeutic HPV Vaccines

8. Cervical Dysplasia Market, by End User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Diagnostic Centers
8.4. Hospitals
8.5. Research & Academic Institutes
8.6. Specialty Clinics

9. Americas Cervical Dysplasia Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cervical Dysplasia Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Cervical Dysplasia Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Asieris Pharmaceuticals
13.3. ASKA Pharmaceutical Co., Ltd.
13.4. Becton, Dickinson, and Company
13.5. BetterLife Pharma Inc.
13.6. Bristol-Myers Squibb Company
13.7. Cardinal Health Inc.
13.8. CooperSurgical Inc
13.9. DYSIS Medical Ltd.
13.10. F. Hoffmann La-Roche Ltd
13.11. GlaxoSmithKline PLC
13.12. Guided Therapeutics, Inc.
13.13. Helix BioPharma Corp.
13.14. Hologic, Inc.
13.15. Karl Kaps GmbH & Co. KG
13.16. KinoPharma, Inc.
13.17. Micromedic Technologies Ltd.
13.18. OncoHealth Corp
13.19. PDS Biotechnology company
13.20. Polaris Pharmaceuticals, Inc.
13.21. Qiagen N.V.
13.22. Quest Diagnostics, Inc.
13.23. ViciniVax B.V.

14. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/1exmtk
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET

source